Cervical cancer cost Eswatini's society an estimated 19 million US dollars in 2018, most of it the direct cost of treating invasive cancer at late stages.
Published as "The economic burden of cervical cancer in Eswatini: Societal perspective". A cost-of-illness study using national clinical and registry data for 2018, counting direct medical costs, patients' travel costs, and productivity lost to illness and early death.
More than half of the total, $10.4 million of $19 million, is the cost of treating stage III and stage IV disease, and less than 1% of direct costs goes on treating pre-cancer. The authors conclude that HPV vaccination and screening should be prioritised.
It is the ministry's own account of the launch, and the baseline against which later coverage figures can be read.
Radiotherapy, which is not available in Eswatini, is the largest cost per patient, and travel and lodging are a cost in their own right.
Shares Manzini Oncology Unit, Ministry of Health, Eswatini, Cervical cancer.
Shares Manzini Oncology Unit, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/